MEDIPOST Receives Approval for Phase III Clinical Trial of CARTISTEM for the Treatment of Osteochondral Cartilage Defects in Ankle Joint

2019/12/03

STEM CELL THERAPEUTIC

MEDIPOST to Expand the GMP facility to increase manufacturing capacity for CARTISTEM and new pipeline of products

2019/11/14

STEM CELL THERAPEUTIC

MEDIPOST Registers the Chinese Patent for a Mesenchymal Stem Cell Culture Method

2019/10/23

STEM CELL THERAPEUTIC

MEDIPOST Treats First Patient with Injectable Cell Therapeutic for Knee Osteoarthritis

2019/10/17

STEM CELL THERAPEUTIC

MEDIPOST’s PNEUMOSTEM Receives Fast Track Designation from the US FDA

2019/08/22

STEM CELL THERAPEUTIC

MEDIPOST Registers European Patent for the Mesenchymal Stem Cell Culture Method

2019/07/24

STEM CELL THERAPEUTIC

MEDIPOST Registers the Canadian Patent for a Mesenchymal Stem Cell Culture Method

2019/06/26

STEM CELL THERAPEUTIC

MEDIPOST’s Injectable Cell Therapeutic for Knee Osteoarthritis Receives Phase 1 Clinical Trial Approval

2019/05/31

STEM CELL THERAPEUTIC

MEDIPOST, announces the clinical trial achievements at Bio USA

2019/05/31

STEM CELL THERAPEUTIC

MEDIPOST, announces a domestic and international clinical experience at the ISCT annual meeting

2019/05/30

STEM CELL THERAPEUTIC

Results from the US Clinical Trial of PNEUMOSTEM for Treating Lung Disease is Published in International Journal

2019/05/13

STEM CELL THERAPEUTIC

MEDIPOST Registers US Patent for the Treatment of Lung Diseases

2019/04/17

STEM CELL THERAPEUTIC